EpiFinder™ cNUC

About Epigenica

Epigenica is a Stockholm-based biotech company pioneering high-throughput, multiplexed epigenetic profiling. Its patented EpiFinder™ platform, powered by hmqChIP-seq and LACODE barcoding technology, enables simultaneous analysis of up to 8 epigenetic markers across 24 samples from low-input materials, including plasma. This positions the company to address significant bottlenecks in epigenetics research and biomarker discovery for diseases like cancer. Epigenica is currently commercializing its first product kits and appears to be a privately-held, pre-revenue or early-revenue platform technology company.